Literature DB >> 21611046

Evaluation of dose coverage to target volume and normal tissue sparing in the adjuvant radiotherapy of gastric cancers: 3D-CRT compared with dynamic IMRT.

Kk Murthy1, Ka Shukeili, Ss Kumar, Ca Davis, Rr Chandran, S Namrata.   

Abstract

PURPOSE: To assess the potential advantage of intensity-modulated radiotherapy (IMRT) over 3D-conformal radiotherapy (3D-CRT) planning in postoperative adjuvant radiotherapy for patients with gastric carcinoma. METHODS AND MATERIALS: In a retrospective study, for plan comparison, dose distribution was recalculated in 15 patients treated with 3D-CRT on the contoured structures of same CT images using an IMRT technique. 3D-conformal plans with three fields and four-fields were compared with seven-field dynamic IMRT plans. The different plans were compared by analyzing the dose coverage of planning target volume using TV(95), D(mean), uniformity index, conformity index and homogeneity index parameters. To assess critical organ sparing, D(mean), D(max), dose to one-third and two-third volumes of the OARs and percentage of volumes receiving more than their tolerance doses were compared.
RESULTS: The average dose coverage values of PTV with 3F-CRT and 4F-CRT plans were comparable, where as IMRT plans achieved better target coverage(p<0.001) with higher conformity index value of 0.81±0.07 compared to both the 3D-CRT plans. The doses to the liver and bowel reduced significantly (p<0.001) with IMRT plans compared to other 3D-CRT plans. For all OARs the percentage of volumes receiving more than their tolerance doses were reduced with the IMRT plans.
CONCLUSION: This study showed that a better target coverage and significant dose reduction to OARs could be achieved with the IMRT plans. The IMRT can be preferred with caution for organ motion. The authors are currently studying organ motion in the upper abdomen to use IMRT for patient treatment.

Entities:  

Keywords:  Conformal radiotherapy; intensity modulated radiotherapy; organs at risk; planned target volume; tolerance doses

Year:  2010        PMID: 21611046      PMCID: PMC3097777          DOI: 10.2349/biij.6.3.e29

Source DB:  PubMed          Journal:  Biomed Imaging Interv J        ISSN: 1823-5530


  22 in total

1.  Prospective randomized trial of combined oncological therapy for gastric carcinoma.

Authors:  D M Dent; I D Werner; B Novis; P Cheverton; P Brice
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

2.  Prognostic factors after curative resection for gastric cancer. A population-based study.

Authors:  S Msika; A M Benhamiche; J L Jouve; P Rat; J Faivre
Journal:  Eur J Cancer       Date:  2000-02       Impact factor: 9.162

3.  Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

Authors:  F Bozzetti; E Marubini; G Bonfanti; R Miceli; C Piano; L Gennari
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Adenocarcinoma of the stomach: univariate and multivariate analysis of factors associated with survival.

Authors:  Dan Green; Sergio Ponce de Leon; Eucario Leon-Rodriguez; Ricardo Sosa-Sanchez
Journal:  Am J Clin Oncol       Date:  2002-02       Impact factor: 2.339

5.  Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques.

Authors:  M T Milano; M C Garofalo; S J Chmura; K Farrey; C Rash; R Heimann; A B Jani
Journal:  Br J Radiol       Date:  2006-06       Impact factor: 3.039

6.  Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma.

Authors:  Richard D Pezner; An Liu; Chunhui Han; Yi-Jen Chen; Timothy E Schultheiss; Jeffrey Y C Wong
Journal:  Radiother Oncol       Date:  2006-09-26       Impact factor: 6.280

7.  Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.

Authors:  Stephen R Smalley; Leonard Gunderson; Joel Tepper; James A Martenson; Bruce Minsky; Christopher Willett; Tyvin Rich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

8.  Intensity modulated radiotherapy in abdominal malignancies: our experience in reducing the dose to normal structures as compared to the gross tumor.

Authors:  Tejinder Kataria; Sheh Rawat; S N Sinha; P S Negi; Charu Garg; N K Bhalla; R K Munjal
Journal:  J Cancer Res Ther       Date:  2006 Oct-Dec       Impact factor: 1.805

9.  Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT.

Authors:  Frank Lohr; Barbara Dobler; Sabine Mai; Brigitte Hermann; Uta Tiefenbacher; Petra Wieland; Volker Steil; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2003-08       Impact factor: 3.621

10.  IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach.

Authors:  Petra Wieland; Barbara Dobler; Sabine Mai; Brigitte Hermann; Uta Tiefenbacher; Volker Steil; Frederik Wenz; Frank Lohr
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

View more
  7 in total

1.  Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity.

Authors:  Alaa Ahmad Nour; Aziz Alaradi; Adel Mohamed; Saleh Altuwaijri; Volker Rudat
Journal:  Radiat Oncol       Date:  2013-09-05       Impact factor: 3.481

2.  The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial.

Authors:  Rhys Carrington; Emiliano Spezi; Sarah Gwynne; Peter Dutton; Chris Hurt; John Staffurth; Thomas Crosby
Journal:  Radiat Oncol       Date:  2016-02-06       Impact factor: 3.481

3.  Assessing the role of volumetric-modulated arc therapy in hepatocellular carcinoma.

Authors:  Mian Xi; Li Zhang; Qiao-Qiao Li; Lei Zhao; Rui Zhang; Meng-Zhong Liu
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

4.  Dosimetric Comparison of Three Different Radiotherapy Techniques in Antrum-Located Stomach Cancer

Authors:  Alparslan Serarslan; Nilgun Ozbek Okumus; Bilge Gursel; Deniz Meydan; Yalcin Dastan; Talat Aksu
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

Review 5.  Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives.

Authors:  A Schernberg; E Rivin Del Campo; B Rousseau; O Matzinger; M Loi; P Maingon; F Huguet
Journal:  Clin Transl Radiat Oncol       Date:  2018-03-13

6.  Effects of changing modulation and pitch parameters on tomotherapy delivery quality assurance plans.

Authors:  Diana Binny; Craig M Lancaster; Selina Harris; Steven R Sylvander
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

7.  Dosimetric comparison of intensity modulated radiotherapy isocentric field plans and field in field (FIF) forward plans in the treatment of breast cancer.

Authors:  Zakiya Salem Al-Rahbi; Zahid Al Mandhari; Ramamoorthy Ravichandran; Fatma Al-Kindi; Cheriyathmanjiyil Anthony Davis; Saju Bhasi; Namrata Satyapal; Balakrishnan Rajan
Journal:  J Med Phys       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.